Triangulation of dispensing and wastewater data for surveillance during lisdexamfetamine shortages: A descriptive time series analysis
Open Access
- 11 October 2026
- journal article
- Published by Wiley in British Journal of Clinical Pharmacology
Abstract
Aims: Lisdexamfetamine, a long‐acting stimulant for attention‐deficit hyperactivity disorder (ADHD), has experienced widespread shortages in Australia since late 2023, raising concerns about treatment continuity and shifts in stimulant use patterns. This study assessed the impact of shortages in South Australia (SA) and Western Australia (WA) by triangulating prescription dispensing and wastewater‐based epidemiology (WBE). Methods: Monthly Pharmaceutical Benefits Scheme (PBS) dispensing data for lisdexamfetamine and dexamfetamine were converted to defined daily doses (DDD) per 1000 population per day. Concurrently, bimonthly wastewater samples from metropolitan sites were analysed for amphetamine and methamphetamine concentrations, with methamphetamine serving as a control as its use was unlikely to be affected by the shortage. Data were compared from February 2022 to December 2024. Results: In WA, lisdexamfetamine DDDs increased from 5.59 to 13.02 and dexamfetamine from 2.55 to 6.03 per 1000 population per day, doubling combined stimulant DDDs from 8.14 to 19.05. In SA, lisdexamfetamine DDDs rose from 1.05 to 5.00. Wastewater amphetamine levels fluctuated (WA: 5.07–17.10; SA: 0.79–3.46 doses/day/1000 people) but declined sharply during shortages, while methamphetamine levels remained high (peaking at 62.65 in WA and 66.22 in SA). Conclusions: Triangulation revealed variations in lisdexamfetamine use during shortages and highlighted potential behavioural responses. While these behaviours may partly explain differences between prescription dispensing and wastewater amphetamine levels, they do not fully account for the observed temporal patterns. Nonetheless, triangulating these data sources offers valuable insights for monitoring medicine use and informing public health and policy responses during supply disruptions.Keywords
Funding Information
- National Health and Medical Research Council (GNT1196900)
This publication has 24 references indexed in Scilit:
- Utilisation Trends of Lisdexamfetamine: Insights From Recent Medicine Shortages in AustraliaPharmacoepidemiology and Drug Safety, 2025
- Core concepts in pharmacoepidemiology: Measures of drug utilization based on individual‐level drug dispensing dataPharmacoepidemiology and Drug Safety, 2022
- Examining the dispensing patterns of antipsychotics in Australia from 2006 to 2018 - A pharmacoepidemiology studyResearch in Social and Administrative Pharmacy, 2021
- Showcasing the potential of wastewater-based epidemiology to track pharmaceuticals consumption in cities: Comparison against prescription data collected at fine spatial resolutionEnvironment International, 2021
- Simultaneous determination of 24 opioids, stimulants and new psychoactive substances in wastewaterMethodsX, 2019
- Enantiomeric profiling of amphetamine and methamphetamine in wastewater: A 7-year study in regional and urban Queensland, AustraliaScience of The Total Environment, 2018
- Data triangulation in the context of opioids monitoring via wastewater analysesDrug and Alcohol Dependence, 2015
- Studies using Australia's Pharmaceutical Benefits Scheme data for pharmacoepidemiological research: a systematic review of the published literature (1987-2013)Pharmacoepidemiology and Drug Safety, 2015
- Sewer epidemiology mass balances for assessing the illicit use of methamphetamine, amphetamine and tetrahydrocannabinolScience of The Total Environment, 2012
- Drug utilization statistics for individual-level pharmacy dispensing dataPharmacoepidemiology and Drug Safety, 2005